| Back |
|
| Your asset for complete success in post operative crisis |
| Product Name: |
| Injection |
| Ondansetron 2 mg |
| Suppresses post-operative effects |
| Safe and effective even when used in children |
| Lacks the sedative, dysphoric and extrapyramidal symptoms associated with droperidol and metoclopramide |
| More effective for preventing PONV, for improving patient satisfaction when administered at the completion of surgery |
| I.V Administration is highly effective in reducing postoperative emesis in children undergoing tonsillectomy and craniofacial operations |
| I.V. ondansetron 4 mg appears to be the optimal dose, and it is more effective than metoclopramide 10 mg in adults in the treatment of established PONV |
|
| Also available: ONDON Tablets (Ondansetron 4 mg & 8 mg), ONDON Syrup (Each 5 ml contain: 2 mg), ONDON-R Injection (Each 5 ml: Ondansetron 2 mg, Ranitidine 25 mg)
|
|
| Post operative nausea & vomiting
|
| Radiotherapy treatment induced nausea & vomiting
|
|
Medical Jr.
| 1. Clin Drug invest 2002;22(9): 561-574
|
| 2. Pediatr Drugs 2002; 4(11): 717-728
|
| 3. J Anesth (2001) 15:223-232
|
|
| |
|
 |